Navigation Links
Signostics Introduces the World's Smallest Ultrasound Product for Global Demands of Affordable Healthcare
Date:10/5/2009

BOSTON, Oct. 5 /PRNewswire/ -- American College of Emergency Physicians 2009 Scientific Assembly -- Signostics Inc., a U.S. and Australian-based medical device company developing innovative portable and affordable handheld medical devices, today announced the launch of its new palm-sized, affordable ultrasound product for point-of-care use by medical practitioners.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091005/SF86741-a)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091005/SF86741LOGO-b)

The Signostics palm-sized ultrasound product has quality image resolution with a touch-screen display, a start time of less than one second from sleep mode and stores up to 10,000 images. Weighing approximately a half pound with a sleek, compact design that fits into the palm of the hand, the product is equivalent to the size of a smart phone. This allows physicians to place the device in their pocket or wear around their neck like a stethoscope until the next use, increasing the convenience of using ultrasound for diagnosis at the point of care.

"Demand for affordable healthcare is a global issue and our product provides physicians with an easy to use, affordable way to improve efficiency and faster triage in the emergency room and other clinical settings. The Signostics palm-sized ultrasound product provides physicians with a quick way to visually assess a patient's internal anatomy that is limited with a stethoscope. Signostics is democratizing ultrasound by making it accessible to a much broader market," said Neil Bartlett, MD, CEO of Signostics Inc.

With additional benefits such as volume measurements, customiz
'/>"/>

SOURCE Signostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. IncentOne Introduces Next Generation of Healthy Choice Award(TM) Incentive Solution to Drive Consumer and Provider Engagement
2. URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation
3. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
4. Health Strategies Group Introduces Oncology Performance Edge
5. Lumenis(R) Introduces AcuPulse(TM) for Fractional Laser Treatments
6. Senate Introduces Bill to Boost Participation in Clinical Trials for Rare Diseases
7. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
8. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
9. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
10. Siemens Introduces New Standard of Care for Breast Ultrasound
11. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
(Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
(Date:1/22/2015)... WOODBRIDGE, ON , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics ... company with a focus on Omega-3 therapies for cardiovascular disease ... summary of the Company,s accomplishments in 2014 and its outlook ... Dear Fellow Shareholders, We would like ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... in Carotid Atherosclerosis, LEXINGTON, Mass., Oct. 24 ... its pivotal clinical trial (PROVIDENCE-1),studying the effect of ... peripheral arterial disease (PAD) will be,presented on November ... late breaker,Scientific Session at the American Heart Association,s ...
... Today the National Legal and Policy,Center (NLPC) asked ... for,International Development (USAID) to investigate the possibility that ... groups operating,needle exchange programs for drug users in ... activist George,Soros are recipients of these legally questionable ...
Cached Medicine Technology:ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting 2ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting 3Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups 2
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
(Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
(Date:1/22/2015)... Plainsboro, NJ (PRWEB) January 22, 2015 ... advocate and keynote speaker at the upcoming 32nd ... by ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , ... breast would have gone undetected if she had not ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... increasing pressure to provide access to expensive new drugs. ... not publicly insured are seeking to pay for these ... CMAJ ( Canadian Medical Association Journal ) (pre-embargo ... by Colleen M. Flood, Canada Research Chair in Health ...
... Patients should avoid taking the two drugs together, researchers ... Women with breast cancer who take both tamoxifen and ... because Paxil reduces tamoxifen,s effectiveness, Canadian researchers report. , ... especially when it is used in combination with tamoxifen ...
... , ... stories are physicians reading to stay informed about key developments? MedPage Today ... Stories for the Past Week will be published Every Monday and will ... of Herbal Meds Reviewed , ICU Catheter Infections ...
... CLEARWATER, Fla. , Feb. 8 Lincare Holdings Inc. ... and year ended December 31, 2009 . , For the quarter ... , compared with net revenues of $415.1 million for the ... net revenues in the fourth quarter of 2009 was comprised of 13% ...
... CHARLOTTE, N.C. , Feb. 8 Medical teams from ... Haiti . Through an agreement with the Department of the Navy, CHS ... providing care to victims of the January earthquake. , The first ... will remain in Haiti for two weeks.  Navy medical officials ...
... Paolo Pandolfi, at Beth Israel Deaconess Medical Center, Boston, ... irreversible arrest of cell growth) and determined a way ... growth in mice. Previous work by Pandolfi and ... to a senescence response that opposes tumorigenesis. In this ...
Cached Medicine News:Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 2Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 3Health News:MedPage Today(R) 'What Your Physicians Are Reading' 2Health News:MedPage Today(R) 'What Your Physicians Are Reading' 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 2Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 4Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 5Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 6Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 7Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 8Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 9Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 10Health News:Carolinas HealthCare System Volunteers to Join Navy Rescue Mission in Haiti 2Health News:Carolinas HealthCare System Volunteers to Join Navy Rescue Mission in Haiti 3
... The Vasotrax is an ... pressure and heart rate non-invasively, ... fact, significantly more accurate than ... On a full battery charge, ...
... (IGF-II) is a 7.5 kDa peptide which is ... to have mitogenic and metabolic actions involved in ... by binding to target cell receptors. IGF-II binds ... receptor, a monomeric protein which also serves as ...
... Leptin is a proteohormone with a molecular weight ... by the ob gene and produced by adipocytes [1,2]. ... in the regulation of body weight [1-3]. In ... in both men and women [4]. A relationship ...
... is synthesized by the parathyroid glands ... decreased extracellular calcium concentrations. PTH prevents ... decreasing calcium excretion by the kidney. ... PTH is rapidly degraded into 4 ...
Medicine Products: